# Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis

> **NCT05772234** · NA · COMPLETED · sponsor: **Changhai Hospital** · enrollment: 1066 (actual)

## Conditions studied

- Pancreatitis, Chronic
- Pancreatic Duct Stone

## Interventions

- **DRUG:** Lactated ringers solution
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT05772234
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-17
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-03-23
- **Target enrollment:** 1066 (ACTUAL)
- **Last updated:** 2025-03-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05772234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05772234, "Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05772234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*